OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Amgen/  US0311621009  /

IEX
7/8/2025  8:12:07 PM Chg. +3.82 Volume Bid7/8/2025 Ask7/8/2025 Market Capitalization Dividend Y. P/E Ratio
296.71USD +1.30% 20,114
Turnover: 5.95 mill.		 296.52Bid Size: 102 296.87Ask Size: 100 159.4 bill.USD 3.08% 38.90
GlobeNewswire 8:22 PM Market Barriers Continue to Challenge PNH Treatment Optimization Despite Emerging Options, According...
GlobeNewswire 1:30 PM Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
GlobeNewswire 7/7 Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chi...
GlobeNewswire 7/3 Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaborati...
GlobeNewswire 7/2 Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
GlobeNewswire 7/1 Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Exe...
GlobeNewswire 7/1 Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advis...
GlobeNewswire 6/25 Aisera Named to Inc.’s 2025 Best Workplaces List
GlobeNewswire 6/23 Galapagos Appoints Aaron Cox as Chief Financial Officer
GlobeNewswire 6/18 Aisera Introduces a System of AI Agents for Faster, Smarter Enterprise Transformation
GlobeNewswire 6/18 Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
GlobeNewswire 6/18 TOLREMO therapeutics Announces Strengthening of Leadership: Alessandra Cesano Joins Board of Directo...
GlobeNewswire 6/17 Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next...
GlobeNewswire 6/17 Saudi Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
GlobeNewswire 6/16 Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
GlobeNewswire 6/11 Ligand Announces 2025 Investor Day in New York City
GlobeNewswire 6/9 Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive App...
GlobeNewswire 6/3 OXB Highlights the Launch of its Innovation and Technology Excellence Board
GlobeNewswire 6/2 Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Offic...
GlobeNewswire 6/2 Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable...
GlobeNewswire 5/29 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 5/22 Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
GlobeNewswire 5/20 VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
GlobeNewswire 5/20 VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
GlobeNewswire 5/19 CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus...